Buscar
-
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study
(Drug Safety. vol. 46, n° 5, pp. 449-456, 2023-05)Article de revue -
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
(Diabetes Care. vol. 46, n° 5, pp. e121-e122, 2023-05-01)Article de revue -
The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France
(Infectious Diseases Now. vol. 53, n° 5, pp. 104717, 2023-05-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Therapies. vol. 78, pp. 213-224, 2023-03)Article de revue -
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study
(Vascular Medicine. pp. 1358863X231209263, 2023-11-07)Article de revue -
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database
(Diabetes, Obesity and Metabolism, 2024-01-30)Article de revueLibre acceso -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre acceso -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre acceso -
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study.
(Acta Psychiatrica Scandinavica. vol. 148, n° 3, pp. 233-241, 2023-09-01)Article de revueLibre acceso